title: Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.
abstract: Interindividual variations in vaccine-induced immune responses are in part due to host genetic polymorphisms in the human leukocyte antigen (HLA) and other gene families. This study examined associations between HLA genotypes, haplotypes, and homozygosity and protective antigen (PA)-specific cellular immune responses in healthy subjects following immunization with Anthrax Vaccine Adsorbed (AVA). While limited associations were observed between individual HLA alleles or haplotypes and variable lymphocyte proliferative (LP) responses to AVA, analyses of homozygosity supported the hypothesis of a "heterozygote advantage." Individuals who were homozygous for any HLA locus demonstrated significantly lower PA-specific LP than subjects who were heterozygous at all eight loci (median stimulation indices [SI], 1.84 versus 2.95, P = 0.009). Similarly, we found that class I (HLA-A) and class II (HLA-DQA1 and HLA-DQB1) homozygosity was significantly associated with an overall decrease in LP compared with heterozygosity at those three loci. Specifically, individuals who were homozygous at these loci had significantly lower PA-specific LP than subjects heterozygous for HLA-A (median SI, 1.48 versus 2.13, P = 0.005), HLA-DQA1 (median SI, 1.75 versus 2.11, P = 0.007), and HLA-DQB1 (median SI, 1.48 versus 2.13, P = 0.002) loci, respectively. Finally, homozygosity at an increasing number (≥ 4) of HLA loci was significantly correlated with a reduction in LP response (P < 0.001) in a dose-dependent manner. Additional studies are needed to reproduce these findings and determine whether HLA-heterozygous individuals generate stronger cellular immune response to other virulence factors (Bacillus anthracis LF and EF) than HLA-homozygous subjects.
authors: Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, USA.
authors: Inna G
authors: IG
authors: Ovsyannikova
authors: V Shane
authors: VS
authors: Pankratz
authors: Robert A
authors: RA
authors: Vierkant
authors: Nicholas M
authors: NM
authors: Pajewski
authors: Conrad P
authors: CP
authors: Quinn
authors: Richard A
authors: RA
authors: Kaslow
authors: Robert M
authors: RM
authors: Jacobson
authors: Gregory A
authors: GA
authors: Poland
mesh_terms: D000293:Adolescent; D000328:Adult; D000483:Alleles; D000881:Anthrax / Q000276:immunology / Q000517:prevention & control; D022122:Anthrax Vaccines / Q000008:administration & dosage / Q000276:immunology*; D000917:Antibody Formation; D001408:Bacillus anthracis / Q000276:immunology* / Q000472:pathogenicity; D049109:Cell Proliferation; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D056426:Genetic Loci; D015234:HLA-A Antigens / Q000276:immunology; D059848:HLA-DQ alpha-Chains / Q000276:immunology*; D059866:HLA-DQ beta-Chains / Q000276:immunology*; D006239:Haplotypes; D006579:Heterozygote; D006650:Histocompatibility Testing; D006720:Homozygote; D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D014611:Vaccination; D055815:Young Adult
chemical_list: D022122:Anthrax Vaccines; D015234:HLA-A Antigens; D059848:HLA-DQ alpha-Chains; D059866:HLA-DQ beta-Chains; C069050:HLA-DQA1 antigen; C069051:HLA-DQB1 antigen
references: Am J Hum Genet. 2002 Feb;70(2):425-34
references: 11791212
references: Clin Vaccine Immunol. 2012 Nov;19(11):1730-45
references: 22933399
references: MMWR Recomm Rep. 2010 Jul 23;59(RR-6):1-30
references: 20651644
references: Science. 1999 Mar 12;283(5408):1748-52
references: 10073943
references: Genes Immun. 2011 Sep;12(6):457-65
references: 21368772
references: Hepatology. 2004 Apr;39(4):978-88
references: 15057902
references: Hum Immunol. 2010 Feb;71(2):128-35
references: 19896518
references: Vaccine. 2009 May 26;27(25-26):3359-66
references: 19200845
references: Hum Immunol. 2004 Dec;65(12):1506-15
references: 15603879
references: Vaccine. 2011 May 9;29(20):3670-8
references: 21420416
references: AIDS Res Hum Retroviruses. 1999 Mar 1;15(4):317-24
references: 10082114
references: Vaccine. 2012 Jul 6;30(32):4778-84
references: 22658931
references: JAMA. 2008 Oct 1;300(13):1532-43
references: 18827210
references: Hum Vaccin. 2007 Sep-Oct;3(5):205-11
references: 17881903
references: Vaccine. 2006 Mar 24;24(14):2530-6
references: 16417950
references: Vaccine. 2009 Nov 16;27(49):6926-31
references: 19761839
references: Infect Immun. 2008 Oct;76(10):4538-45
references: 18678674
references: PLoS One. 2012;7(7):e40882
references: 22815851
references: Infect Immun. 1993 Dec;61(12):5294-301
references: 8225603
references: Vaccine. 2007 Feb 26;25(10):1848-55
references: 17240488
references: Clin Pharmacol Ther. 2007 Dec;82(6):653-64
references: 17971814
references: Mol Aspects Med. 2009 Dec;30(6):490-502
references: 19729034
references: Hum Immunol. 2005 Jul;66(7):788-98
references: 16112026
references: Nat Genet. 1997 Sep;17(1):11-2
references: 9288086
references: Vaccine. 2009 May 26;27(25-26):3349-58
references: 19200828
references: Vaccine. 2008 Feb 13;26(7):869-73
references: 18206278
references: N Engl J Med. 1989 Sep 14;321(11):708-12
references: 2528067
references: Clin Infect Dis. 2001 Nov 1;33(9):1604-7
references: 11577377
references: Immunol Allergy Clin North Am. 2003 Nov;23(4):713-30
references: 14753388
references: J Infect Dis. 2002 Jun 1;185(11):1545-9
references: 12023759
references: Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
references: 20463105
references: Tissue Antigens. 2010 Apr;75(4):291-455
references: 20356336
references: Hepatology. 2007 Dec;46(6):1713-21
references: 17935228
references: Lancet Infect Dis. 2006 Oct;6(10):653-63
references: 17008174
references: Vaccine. 2006 Aug 14;24(33-34):5950-9
references: 16797805
references: Infect Immun. 2000 Apr;68(4):1781-6
references: 10722564
references: Infect Immun. 2005 Sep;73(9):5978-87
references: 16113318
references: Hum Immunol. 2004 Mar;65(3):209-17
references: 15041159
references: J Immunol. 2010 Apr 1;184(7):3814-21
references: 20208010
references: Immunogenetics. 2005 Feb;56(11):798-807
references: 15712014
references: Vaccine. 2011 Oct 19;29(45):7982-91
references: 21872631